Loading market data...
ADVERTISEMENT
Banner
Latest Top News

No Observations, No Delays—Natco Pharma’s FDA Inspection Ends on a Strong Note

Unknown Apr 02, 2026 2 Views
No Observations, No Delays—Natco Pharma’s FDA Inspection Ends on a Strong Note
Natco Pharma Ltd has successfully completed a US FDA inspection at its Hyderabad facility, a key regulatory milestone for the company. The October 30November 1, 2023, inspection for compliance of pharmacovigilance resulted in zero observations, affirming Natco's adherence to international qua...
Show more

Stay Ahead – Explore Now! Storm Watch in the Hills: IMD Issues Orange Alert for Himachal Pradesh from Jan 26